Intravenous Immunoglobulin and Dermatomyositis-Associated Venous Thromboembolism

JAMA Dermatol. 2023 Jun 1;159(6):666-667. doi: 10.1001/jamadermatol.2023.1105.
No abstract available

Plain language summary

This cohort study investigated the association between treatment of dermatomyositis with intravenous immunoglobulin and thromboembolic events.

MeSH terms

  • Dermatomyositis* / complications
  • Dermatomyositis* / diagnosis
  • Dermatomyositis* / drug therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Risk Assessment
  • Risk Factors
  • Venous Thromboembolism* / diagnosis
  • Venous Thromboembolism* / drug therapy
  • Venous Thromboembolism* / etiology

Substances

  • Immunoglobulins, Intravenous